Development of Recombinant Oncolytic rVSV-mIL12-mGMCSF for Cancer Immunotherapy.
Ryapolova A, Minskaia E, Gasanov N, Moroz V, Krapivin B, Egorov AD, Laktyushkin V, Zhuravleva S, Nagornych M, Subcheva E, Malogolovkin A, Ivanov R, Karabelsky A.
Ryapolova A, et al. Among authors: egorov ad.
Int J Mol Sci. 2023 Dec 22;25(1):211. doi: 10.3390/ijms25010211.
Int J Mol Sci. 2023.
PMID: 38203382
Free PMC article.